Covalon Technologies Ltd. (OTCMKTS:CVALF - Get Free Report) shot up 19.5% during mid-day trading on Thursday . The stock traded as high as $1.84 and last traded at $1.84. 5,800 shares traded hands during mid-day trading, a decline of 71% from the average session volume of 19,910 shares. The stock had previously closed at $1.54.
Covalon Technologies Stock Performance
The stock's 50 day moving average is $1.83 and its 200 day moving average is $2.21. The company has a market capitalization of $44.14 million, a PE ratio of 23.00 and a beta of 0.19.
Covalon Technologies (OTCMKTS:CVALF - Get Free Report) last posted its earnings results on Friday, February 21st. The company reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.03) by $0.06. The firm had revenue of $5.84 million for the quarter, compared to the consensus estimate of $6.37 million. Covalon Technologies had a return on equity of 12.33% and a net margin of 8.58%.
About Covalon Technologies
(
Get Free Report)
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.
Featured Articles
Before you consider Covalon Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Covalon Technologies wasn't on the list.
While Covalon Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
